Health Economics and Policy

With the pandemic putting frontline health workers under mounting pressure, is it possible for ophthalmologists to safely see patients?

The glaucoma subspecialty is now at a turning point, but new approaches, including MIGS, must be based on high-quality evidence

The DARPin platform has the AMD and DME treatment burden firmly in its sights – but that’s only the beginning

Organ-to-cloud technology is here – and it has its sights set on glaucoma

How important is a joint-up approach to caring for patients with diabetes and diabetic eye disease?

Clark E. Tedford tells us about his part in creating LumiThera, its flagship product and technology, and the company’s plans for the future

In a new series, we present ophthalmology’s most inspiring figures, as told by those closest to them – beginning with the unsurpassable Fred Hollows

The standard of care for wet AMD presents a big burden for patients, so what other options are out there?

Leading ophthalmic bodies warn that COVID-19 can be transmitted through aerosol contact with the conjunctiva

How surgical adjuncts can make cataract surgery safer – and minimize costs in the long run